<?xml version="1.0" encoding="UTF-8"?>
<p>In conclusion, the patient had TRMA induced by maternal-UPD-involved c.515G&gt;A(p.G172D) homozygous mutation of 
 <italic>SLC19A2</italic>. The genetic diagnosis of TRMA is of significance for guiding clinical treatment. Early treatment with exogenous thiamine can improve some of the clinical features of TRMA.
</p>
